Avricore Health (AVCRF) Other Non-Current Liabilities (2017 - 2025)
Avricore Health (AVCRF) posted quarterly Other Non-Current Liabilities of $77445.3 for Q4 2025, up 377.97% sequentially from $16202.9 in Q4 2019.
Avricore Health (AVCRF) Other Non-Current Liabilities (2017 - 2025) Analysis & Trends
Avricore Health has disclosed Other Non-Current Liabilities across 3 years of filings, most recently posting $77445.3 for Q4 2025.
- In Q4 2025, Other Non-Current Liabilities changed N/A year-over-year to $77445.3; the TTM figure through Dec 2025 stood at $77445.3 (changed N/A YoY), while the FY2025 annual figure was $77297.9, changed N/A from the prior year.
- Other Non-Current Liabilities climbed to $77445.3 in Q4 2025, from $16202.9 in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for AVCRF reached as high as $77445.3 in Q4 2025 and fell as low as $77445.3 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Avricore Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 77,445.32 |
| Dec 31, 2019 | 16,202.89 |
| Dec 31, 2017 | 78,714.22 |